Welcome to our dedicated page for 10X Genomics news (Ticker: TXG), a resource for investors and traders seeking the latest updates and insights on 10X Genomics stock.
10x Genomics, Inc. reports developments in single cell and spatial biology, including financial results, product launches and collaborations tied to its research platforms. The company sells integrated instruments, consumables and software used by academic, translational and biopharmaceutical researchers to analyze biological systems at single-cell and spatial resolution.
Recurring updates cover platforms such as Chromium, Visium, Xenium and Atera; consumables demand; spatial whole-transcriptome analysis; research collaborations and data-generation initiatives; conference presentations; and management commentary on revenue, cash resources and outlook. Company news also reflects applications in oncology, immunology, neuroscience and other disease research areas.
10x Genomics (Nasdaq: TXG) will participate in the BofA Securities Virtual Healthcare Conference on May 13, 2020, at 8:00 a.m. Pacific Time. A live and archived webcast will be available on the company’s Investors section of their website.
The company specializes in life science technologies, producing solutions for understanding biology to improve health. Their products are widely used by top global research institutions and pharmaceutical companies, featuring over 700 patents and cited in over 700 research papers.